Login    Join free Add to favorites    中文
Home >Products> Reagents >Biochemistry> Pasireotide
Pasireotide
Origin of place United States
Model 396091-73-9
Supplier BOC Sciences
Price $598
Hits 114
Updated 2/10/2023
  • Product Detail
  • Company Profile
Pasireotide pamoate, also known as SOM230, is an orphan drug approved for the treatment of Cushing's disease in patients who fail or are ineligible for surgical therapy. It was developed by Novartis. Pasireotide is a somatostatin analog with a 40-fold increased affinity to somatostatin receptor 5 compared to other somatostatin analogs.https://www.bocsci.com/product/pasireotide-cas-396091-73-9-465329.html
bio-equip.cn
Request Infomation

* Name:
Title:
* Tel:
Fax:
* E-mail:
Postcode:
Institution/Company:
Address:
* Country:
Request infomation:
yes no
Request Quotation:
yes no
* Message:
Validated Code:
refresh
I agree to share my inquiry to the other matching suppliers.



Recently viewed products
Copyright(C) 2006-2025 Bio-Equip    E-mail:web@bio-equip.cn   沪ICP备06040519号